Amrita Institute of Medical Sciences had a phenomenal growth in a short period of 17 years and today “excellence has become our specialty” in healthcare delivery, education and research.

Our 125 acre healthcare campus boasts of vibrant mix of medicine, science and technology.

With AIMS Model of Care and our 670 strong faculty members drawn from the best institutes across the world, over 2500 students annually will be well prepared to succeed in any medical practice setting, from private practice, to academic medicine, to global outreach healthcare.

health-science prospectes

Dentistry -admissions




⇒ For any admission & other enquiries, contact: 

The Admission Co-ordinator, 
Amrita School of Medicine,
AIMS Ponekkara P.O,
Pin : 682041

Healthscience Contact 0484-2858373

Healthscience Contact 0484-2858374

Healthscience Contact 0484-2858383

Healthscience Contact

Healthscience Contact

October 26, 2016
Dr. Antonella Delle Fave, MD Professor at Faculty of Medicine, University of Milan, visited Amrita Centre for Advanced Research in Ayurveda (ACARA) at the Amrita School of Ayurveda. Antonella Delle Fave is a medical doctor specializing in Health Psychology.  Prof. Antonella Delle Fave has an illustrious body of research work to her credit and is currently the Editor-in-Chief of the Springer group’s Journal of Happiness Studies. She has been the President of IPPA, ENPP & SIPP. She has also studied Ayurveda, completing the 4 years Masters Program in Ayurveda at Ayurvedic Point, Milan, Italy, which is run by Dr. Antonio Morandi, MD, a Neurologist turned Ayurveda Physician. She has worked on the assessment of Prakriti or constitution using psychometric tools. Dr. Antonella addressed the PG Scholars at Amrita School of Ayurveda, interacted with Br. Sankara Chaitanya, Medical Director, Dr. P. Ram Manohar, Research Director, Dr. Rabinarayan Tripathy, Vice Principal and other faculty at Amrita School of Ayurveda during her visit. She also visited Amrita Institute of Medical Sciences, Kochi and interacted with Dr. Sudheeran, Neurologist and Dr. Shantikumar Nair, Dean of Research, Amrita Vishwa Vidyapeetham (University). During the discussions, potential areas for collaboration between Amrita Vishwa Vidyapeetham (University) and University of Milan were explored.
October 14, 2016
B.Sc. Respiratory Therapy students of Amrita Centre for Allied Health Sciences, Kochi, won prizes for intercollegiate poster and quiz competition held as part of the 10th National Conference of Respiratory Therapists (RESCARE - 2016) at CMC Vellore held during October 6-8, 2016. The prize winners are:  POSTER COMPETITION  First prize:- Sneha Varier, B. Sc. RT 2014 batch Second prize:- Marva Palapatta, B. Sc. RT 2014 batch   QUIZ COMPETITION Second prize:- Pinky Rajan, B. Sc. RT 2013 batch Third prize:- Meghalakshmi R., B. Sc. RT 2014 batch
October 12, 2016
Scientists at the Amrita Centre for Nanosciences and Molecular Medicine at Amrita University, Kochi, have come a step closer to using photodynamic therapy for treating residual cancer cells of a high-grade brain tumour (glioblastoma). Photodynamic therapy uses a photosensitive drug that becomes active under the action of light and converts molecular oxygen into reactive oxygen species that kill cancer cells. While the photosensitive drug injected into the body intravenously is not cancer­ cell specific and is less efficient in absorbing light to generate reactive oxygen species, scientists at the Amrita Institute have turned to nanotechnology and used light in the near­ infrared region to achieve better results. Light in the near ­infrared region can penetrate to about 0.8 cm into body tissues. “The drug encapsulated in a nanoparticle has peptides functionalized on its surface and is selectively absorbed only by cancer cells. The nanoparticles containing the drug have better ability to kill cancer cells as they absorb three times more light in the near IR region than the free drug,” says Dr. Manzoor Koyakutty from the Amrita Centre for Nanosciences and Molecular Medicine. “We have incorporated a photosensitizer into the nanoparticle to enhance the light absorption capacity.” Dr. Koyakutty had carried out studies on mice while he was in Erasmus University Rotterdam, the Netherlands. A unique chemical bonding used for anchoring the photosensitizer to the nanoparticle increases the stability of the drug by as much as nine times, says Dr. Koyakutty. The prolonged period of stability of the drug provides a longer window for therapy; Light in the near infrared range can now be given in fractions to activate the drug at regular intervals. “Even if the tumour mass is removed from the brain, some residual cancer cells will be present near the tumour site. We can’t remove healthy brain tissue that contains some cancer cells. So once you remove the tumour mass we can apply the nanoparticles containing the drug at the site where the tumour was present and use near ­IR [light] to kill cancer cells in the neighbouring areas,” says Dr. Shantikumar Nair, Director of the Centre. “Recurrence is very high in the case of glioma. Patients don’t have a cure if it recurs. So if recurrence can be prevented patients can have substantial additional life,” says Dr. Nair. “Photodynamic therapy is a well-known treatment option but can be used only when cancers are near the skin as light cannot penetrate deep. So it has not become a popular treatment option but has potential,” says Dr. Rajiv Sarin, Professor, Radiation Oncology and in­charge of Cancer Genetics Unit at Tata Memorial Hospital, Mumbai. “Getting clinical benefits in patients with cancer is more challenging as cancer is seldom near the surface.” The scientists are planning to undertake studies on mice and then larger animals.
October 8, 2016
Amrita Centre for Nanosciences and Molecular Medicine’s faculty member and research students won various awards at the 11th Asia Pacific Chitin and Chitosan Symposium and the 5th Indian Chitin and Chitosan Society Symposium organised by Indian Chitin and Chitosan Society and Marshall Marine Products, from September 28-30, 2016, at IMA House, Cochin, India. Dr. R. Jayakumar, Professor, Amrita Centre for Nanosciences and Molecular Medicine, received the Best Faculty Researcher Awardfor his outstanding contribution towards chitin/chitosan research. Deepthi Sankar, PhD student at Amrita Centre for Nanosciences and Molecular Medicine, received the Best Student Researcher Award for the year 2015-2016. Her presentation was titled, "Chitin/Chitosan based Matrices for Tissue Engineering and Regenerative Medicine’". Annapoorna Mohandas, PhD student, at Amrita Centre for Nanosciences and Molecular Medicine, who presented her work titled, "Nanocurcumin Incorporated Chitosan-Arginine Composite Injectable Hydrogel for the Enhancement of Angiogenesis in Hind-limb Ischemia" received Best Oral Presentation Award at the Symposium. A. Sivashanmugham, PhD student, received the Best Poster Presentation Award for his work titled "Injectable Nanocomposite Hydrogels for Craniofacial Bone Defects". Gaurav Baranwal, PhD student, received the Best Poster Presentation Award for his work entitled "Treatment of Staphylococcus aureusInfection Using Chitosan-PRP Nano Tigecycline Composite Hydrogel in Drosophila Melanogaster Model". Chitin and Chitosan Society was initiated in 2009. It mainly focuses in promoting cutting edge technological advancements in areas that involve chitin, chitosan and its derivatives. Indian Chitin and Chitosan Society organize national conferences and workshops every year. The Chitin and Chitosan Society aims at creating a link between researchers and industry personnel to bring better scientific developments to this field. Life time achievement award for senior faculty and best researcher award for research students are awarded every year to honour their extraordinary research contribution and to motivate good quality research work in the field of chitin and chitosan research.
Amrita Darshanam - International Centre for Spiritual Studies (ICSS), in association with Indira Gandhi National...
The Department of Electronics Communication and Engineering, Coimbatore will organise a National Workshop on Image...
The Mechatronics & Intelligence Systems Research Lab, Department of Mechanical Engineering, Amrita Vishwa...
Amrita Multi Modal Applications Using Computer Human Interaction (AMMACHI) Labs, of Amrita University Amritapuri campus will...
The department of Sciences, Amrita School of Engineering, Amrita Vishwa Vidyapeetham, Coimbatore Campus is organizing the...

About Healthscience Campus

In the eighteen years since its inception, Amrita Institute of Medical Sciences (AIMS) has grown from a 115 bed specialty hospital to a 1450 bed super-specialty tertiary care health center with an attached medical college hospital. On the 17th of May 1998, AIMS was inaugurated by the then Prime Minister of India, Shri Atal Bihari Vajpayee, in the presence of Her Holiness, Sri Mata Amritanandamayi Devi. The Amrita Institute of Medical Sciences is the adjunct to the term "new universalism" coined by the World Health Organization. This massive healthcare infrastructure with over 3, 330, 000 sq. ft. of built-up area spread over 125 acres of land supports a daily patient volume of about 3000 outpatients with 95 percent inpatient occupancy. Annual patient turnover touches an incredible figure of over 800, 000 outpatients and nearly 54, 800 inpatients.

The hospital has received the ISO 9001-2008 accreditation. It also enjoys accreditation from the National Accreditation Board for Testing and Calibration Laboratories (NABL) for its laboratories and the National Accreditation Board for Hospitals and Healthcare Providers (NABH) for the hospital overall. AIMS is part of the Health Sciences campus of Amrita Vishwa Vidyapeetham. The University is accredited by the National Assessment and Accreditation Council (NAAC) with the highest grade of A. »»